Looking for a trusted Stock Remisier? Augustine works closely with a small group of clients - providing regular market updates, Bazi & astrology wealth insights, and clear guidance to invest with confidence.
2022 profit margins expanded due to strong performance from the Healthcare Services segment
Raffles Medical is facing a global shortage of healthcare workers
TCFs will continue to contribute in the near term
Increased contributions are expected as China operations pick up steam.
With tailwinds and currently trading at attractive valuations, we maintain BUY. Target price: S$1.90.
Outperformance from Healthcare Services
Despite tapering COVID-19-related activities, Raffles Medical Group (RFMD) noted that the increase in 2022 profit margin for the Healthcare Services segment was led by better operating leverage due to higher volume of operations in 2022.
However, the group expects margins to taper off to historical norms moving forward. This is in line with our expectations. RFMD had an exceptionally high margin of 63.1% in 2022 due to annual cost savings of S$67m yoy.
With domestic inflationary pressures and a shortage of nurses in Singapore, we expect staff costs to inch back up to the historical average of 50% from 45%.
Raffles Medical is coping with inflationary pressure
Facing a global shortage in healthcare personnel coupled with salary inflation, RFMD believes that the group will face inflationary cost push
moving forward.
This is in line with expectations and we believe the implemented price increases in 2022 will help to mitigate the expected increases in manpower costs.
Also, in our view, with the tapering of some lower-margin COVID-19 services, better operating leverage and cost efficiencies, a more favourable revenue mix may help soften the decline in margins.
TCFs still as important
Shareholders raised queries about the growth prospects of RFMD’s transitional care facilities (TCF), with the group stating that TCFs continue to assist the government in freeing up space in public hospitals given the ongoing bed crunch.
With the Singapore government’s renewed focus on TCFs, RFMD mentioned that TCFs could continue to play an important part in Singapore’s healthcare system but also shared that TCFs were not a targeted growth area.
This was expected as, from our standpoint, TCFs still face a regulatory risk whereby the government may deem them redundant.
However, Singapore’s health minister mentioned that TCFs would be retained and become “a medium- or even long-term feature of our healthcare system”, making the redundancy of TCFs unlikely.
Although COVID-19 has become endemic in Singapore, TCFs still function as step-down care facilities which play a vital part in the domestic healthcare system.
Furthermore, with an upcoming TCF tender in the west, winning the tender to operate a second TCF would help boost RFMD’s 2023-24 net profit significantly, given that the current TCF contributes around 35% of 2022 operating profit based on our calculations.
Raffles Medical Valuation
Maintain BUY with an unchanged PE-based target price of S$1.90, pegged to an unchanged 26x 2023F PE, -0.5SD to RFMD’s long-term average mean PE.
Backed by favourable tailwinds, we like RFMD for its cheap 2023F PE valuation (18.2x) compared to regional peers (35.4x).
Raffles Medical share price chart
You can find the full report here and the company website here.
Be A Valued Client of Augustine in Lim&Tan Securities
Receive Augustine’s regular stock updates via Telegram plus full access to his private client hub with exclusive research, astrology and Bazi insights.
(Exclusive Readings for Clients Only)
BaZi investment loss prediction is an ancient yet highly practical approach to understanding financial timing using Chinese astrology. In BaZi (八字), also known as the Four Pillars of Destiny, your birth chart reveals how the Five Elements (Wood, Fire, Earth, Metal, Water) interact to shape your personality, opportunities, and wealth potential. Among these, the Wealth
When market sentiment turns upbeat and investors begin looking beyond the large-cap names for fresh drivers of growth, Singapore’s small cap stocks could quietly offer outsized upside. With interest rates stabilising, infrastructure spending picking up, and niche sectors recovering, several overlooked companies may shine in the next market rally. Here are four SGX-listed small-caps worth
You don’t need to be the next Warren Buffett to succeed in investing. But you do need to find your own investing style – so that you compound your wealth that fits your personality, lifestyle, and long-term goals. The truth is, there’s no “one size fits all” approach. Some investors love diving into spreadsheets. Others
Investing in the stock markets can be tricky and you will probably lose hell a lot of money even before making any if you lack the right guidance. Thus, as a beginner, it’s important to avoid making the common mistakes that others have made. In fact, these mistakes offer paramount lessons for you to cut
